Collectively, these data suggest that the ECM/stromal gene signature may arise from peritumoral CD90+CD73+ cells, which we previously demonstrated dysregulated perivascular-like function27 and shown to be the cell of origin of CAFs in well-defined murine models of cancer.20 The gene discussed is NT5E; the disease is cancer.